Immuno Vaccine Inc (IMV)

[John-Knee]

ImmunoVaccine Inc. (IMV) Insider Buys C$10,800.00 in Stock
Posted by Grant Hamersma on May 4th, 2017

ImmunoVaccine Inc. (TSE:IMV) insider Pierre Labbé acquired 10,000 shares of the business’s stock in a transaction that occurred on Monday, April 17th. The shares were purchased at an average cost of C$1.08 per share, for a total transaction of C$10,800.00.

Pierre Labbé also recently made the following trade(s):
On Tuesday, April 18th, Pierre Labbé acquired 10,000 shares of ImmunoVaccine stock. The shares were purchased at an average cost of C$1.13 per share, for a total transaction of C$11,300.00.

On Tuesday, February 28th, Pierre Labbé acquired 15,000 shares of ImmunoVaccine stock. The shares were purchased at an average cost of C$1.17 per share, for a total transaction of C$17,550.00.

On Monday, February 27th, Pierre Labbé purchased 10,000 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.17 per share, for a total transaction of C$11,700.00.

On Monday, February 13th, Pierre Labbé purchased 2,400 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.12 per share, for a total transaction of C$2,688.00.

On Tuesday, February 14th, Pierre Labbé purchased 5,000 shares of ImmunoVaccine stock. The shares were bought at an average cost of C$1.18 per share, for a total transaction of C$5,900.00.

Shares of ImmunoVaccine Inc. (TSE:IMV) opened at 1.61 on Thursday. ImmunoVaccine Inc. has a one year low of $0.51 and a one year high of $1.62. The stock’s market cap is $191.52 million. The stock’s 50 day moving average is $1.22 and its 200-day moving average is $0.94.